Improving T-Cell Function with Epigenetic & Genetic Reprogramming to Improve Cell Therapy Outcomes in Solid Tumours

Time: 5:30 pm
day: Day 1 – Track C – Evening


• Epigenetic reprogramming (Epi-R) results in durable stemness of T-cells
• Genetic reprogramming (Gen-R) limits T-cell exhaustion after infusion to reverse the suppressive effects of the tumour microenvironment and continuous antigen stimulation
• These technologies are being evaluated in all T-cell modalities, CAR-T cells (CAR), TCR engineered T-cells (TCR), and tumour infiltrating lymphocytes (TIL) products